Lund Vasculitis Epidemiology Research Group
1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Malignancies In Giant Cell Arteritis : A Population-Based Cohort Study
Stamatis, Pavlos LU
;
Turesson, Carl
LU
;
Willim, Minna
LU
;
Nilsson, Jan-Åke
LU
;
Englund, Martin
LU
and
Mohammad, Aladdin J
LU
(2020)
In Journal of Rheumatology
47(7).
p.400-406
Mark
-
Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden
Stamatis, Pavlos LU
;
Turkiewicz, Aleksandra
LU
;
Englund, Martin
LU
;
Jönsson, Göran
LU
;
Nilsson, Jan-Åke
LU
;
Turesson, Carl
LU
and
Mohammad, Aladdin
LU
(2020)
In Journal of Rheumatology
47(6).
Mark
- 2019
- Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis
- Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
-
PREVALENCE OF BIOPSY-PROVEN GIANT CELL ARTERITIS IN SOUTHERN SWEDEN
Stamatis, Pavlos LU
;
Turkiewicz, Aleksandra
LU
;
Englund, Martin
LU
;
Turesson, Carl
LU
and
Mohammad, Aladdin
LU
(2019)
The 19th International Vasculitis and ANCA workshop
In Rheumatology
58(Suppl 2).
Mark
-
Coronary Artery Disease in a Population-Based Cohort of Biopsy-Proven Giant Cell Arteritis in Southern Sweden
Stamatis, Pavlos LU
;
Mohammad, Moman
LU
;
Merkel, Peter A
;
Englund, Martin
LU
;
Turesson, Carl
LU
;
Erlinge, David
LU
and
Mohammad, Aladdin
LU
(2019)
American College of Rheumatology
In Arthritis & Rheumatology
71(Suppl 10).
Mark
- 2018
- Brief Report : Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)
-
Hospitalizations due to systemic connective tissue diseases: : Secular trends and regional disparities in Sweden, 1998-2016
Kiadaliri, Aliasghar A LU
;
Mohammad, Aladdin J
LU
and
Englund, Martin
LU
(2018)
In International Journal of Rheumatic Diseases
21(11).
p.1900-1906
Mark
- Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)
- Comment on : Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature